Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The metric has seen a significant loss of -82.30% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -71.98%. Over the past 30 days, the price of PSTV has fallen by 1.91%. And in the last five days, it has surged by 11.91%.
The stock of Plus Therapeutics Inc (PSTV) is currently priced at $0.34. In the last session, the stock climbed significantly, topping out at $20.5 after opening at $0.34. The day’s lowest price was $3.0 before the stock closed at $0.36.
Plus Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.31 on 03/07/25 and the lowest value was $0.16 on 06/18/25.
52-week price history of PSTV Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Plus Therapeutics Inc’s current trading price is -85.44% away from its 52-week high, while its distance from the 52-week low is 105.81%. The stock’s price range during this period has varied between$0.16 and $2.31. The Plus Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 5.52 million for the day, a figure considerably lower than their average daily volume of 26.95 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Plus Therapeutics Inc (PSTV) has experienced a quarterly decline of -57.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 17.15M and boasts a workforce of 21 employees.
Plus Therapeutics Inc: Analysts’ Ratings Unveiled
As of right now, 1 analyst is rating Plus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6491, with a change in price of -0.8437. Similarly, Plus Therapeutics Inc recorded 26,351,471 in trading volume during the last 100 days, posting a change of -71.50%.
PSTV Stock Stochastic Average
As of today, Plus Therapeutics Inc’s raw stochastic average for the last 50 days stands at 29.69%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 63.66%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 68.34% and 68.60%, respectively.